Increased Soluble Thrombomodulin in Hemodialysis Patients with Long-term Erythropoietin Treatment: What Does it Reflect?-Reference-Cited by-同舟云学术

Increased Soluble Thrombomodulin in Hemodialysis Patients with Long-term Erythropoietin Treatment: What Does it Reflect?

Published:2003-10 Issue:4 Volume:9 Page:349-352
ISSN:1076-0296
Container-title:Clinical and Applied Thrombosis/Hemostasis
language:en
Short-container-title:Clin Appl Thromb Hemost

Author:

Stasko Jan,Kubisz Peter¹

Affiliation:

1. Department of Hematology and Blood Transfusion, National Hemostasis and Thrombosis Centre, Jessenius Medical School, Comenius University, Martin, Slovak Republic

Publisher

SAGE Publications

Subject

Hematology,General Medicine

Link

http://journals.sagepub.com/doi/pdf/10.1177/107602960300900413

Reference14 articles.

1. Effects of Recombinant Erythropoietin Therapy on Circulating Endothelial Markers in Hemodialysis Patients

2. Tissue Factor and Thrombomodulin in Hemodialysis Patients: Associations with Endothelial Injury, Liver Disease, and Erythropoietin Therapy

3. Increased Soluble Thrombomodulin Does Not Always Indicate Endothelial Injury

4. Soluble thrombomodulin is associated with viral hepatitis, blood pressure, and medications in haemodialysis patients

5. Plasma von Willebrand factor and thrombomodulin as markers of vascular disorders in patients undergoing regular hemodialysis therapy

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Leptin and plasminogen activator inhibitor-1 levels in children on chronic dialysis;Renal Failure;2013-07-23

2. Regulation of Erythropoietin Receptor Activity in Endothelial Cells by Different Erythropoietin (EPO) Derivatives: An in Vitro Study;International Journal of Molecular Sciences;2013-01-24

3. Long-term erythropoietin therapy does not affect endothelial markers, coagulation activation and oxidative stress in haemodialyzed patients;Thrombosis Research;2007-01